Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.62 USD | -0.61% | -2.98% | -44.37% |
Apr. 11 | BTIG Starts Carisma Therapeutics With Buy Rating, $6 Price Target | MT |
Apr. 02 | HC Wainwright Adjusts Price Target on Carisma Therapeutics to $9 From $11, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-44.37% | 67.71M | |
-1.88% | 102B | |
+2.31% | 96.09B | |
+2.13% | 22.28B | |
-16.88% | 21.4B | |
-8.79% | 18.14B | |
-39.98% | 17.02B | |
-13.94% | 16.09B | |
+4.84% | 13.83B | |
+33.13% | 11.97B |
- Stock Market
- Equities
- CARM Stock
- News Carisma Therapeutics, Inc.
- Carisma Therapeutics Q4 Net Loss Narrows, Revenue Rises; Plans Job Cuts in Q2 -- Shares Decline